Cancer Diagnostics

ITUS Corporation is developing a platform called Cchek™, a series of inexpensive non-invasive blood tests for the early detection of cancer.

Cancer Therapeutics

ITUS is developing chimeric antigen receptor T-cell (CAR T) therapies which genetically engineer a patient's own immune cells to fight cancer.

Strong Leadership Backed by Success

Our management team has had many successes, especially in connection with starting, building and investing in technology related companies.

View Management Team

View Board of Directors